|
 |
|
|
|
|
Phyllanthus (Phyllanthus amarus and niruri), 144 |
|
|
|
 |
|
|
|
|
Physiomedicalism, herbal medicine, 4-5 |
|
|
|
 |
|
|
|
|
Phytochemicals, 40, 48-49, 50t-51t, 68t |
|
|
|
 |
|
|
|
|
anticarcinogenic activities, 94, 95t, 96, 96t |
|
|
|
 |
|
|
|
|
Phytolacca americana, 112 |
|
|
|
 |
|
|
|
|
Phyto Pharmica, distributor, 389, 390, 391, 395 |
|
|
|
 |
|
|
|
|
Pilocarpine jaborandi, 139-140, 306 |
|
|
|
 |
|
|
|
|
Pinus maritima, flavonoid, 209 |
|
|
|
 |
|
|
|
|
Pioneer Nutritional Formulas, distributor, 391, 395 |
|
|
|
 |
|
|
|
|
Pipsissewa (Chimaphila), cancer treatment, 144 |
|
|
|
 |
|
|
|
|
Plant sterols, 52 |
|
|
|
 |
|
|
|
|
Plaster, herbal preparation, 124b |
|
|
|
 |
|
|
|
|
Platelet levels, blood chemistry, 11 |
|
|
|
 |
|
|
|
|
Podophyllum, 141-142 |
|
|
|
 |
|
|
|
|
Point mutations, proto-oncogenes, 20 |
|
|
|
 |
|
|
|
|
Poke (Phytolacca americana), lymphatic herb, 112 |
|
|
|
 |
|
|
|
|
Poke oil, FBD, 334 |
|
|
|
 |
|
|
|
|
Pokeweed antiviral protein (PAP), 112 |
|
|
|
 |
|
|
|
|
Polycyclic hydrocarbons, chemical carcinogen, 27 |
|
|
|
 |
|
|
|
|
Polygonum multiflorum, 114, 139 |
|
|
|
 |
|
|
|
|
Polymer-fume fever, 355 |
|
|
|
 |
|
|
|
|
Poria cocos, 158, 159t |
|
|
|
 |
|
|
|
|
Portobello Mushrooms, 359 |
|
|
|
 |
|
|
|
|
Postradiation tea, 314 |
|
|
|
 |
|
|
|
|
Potassium iodide, 190-191 |
|
|
|
 |
|
|
|
|
FBD, 334t |
|
|
|
 |
|
|
|
|
Potassium, nutritional supplement, 189-191, 215t |
|
|
|
 |
|
|
|
|
Potatoes, 56 |
|
|
|
 |
|
|
|
|
Poultice, herbal preparation, 124b |
|
|
|
 |
|
|
|
|
Poultice powder, formula for, 173-174 |
|
|
|
 |
|
|
|
|
Poustinia, 250 |
|
|
|
 |
|
|
|
|
Poustinki, 250-251 |
|
|
|
 |
|
|
|
|
Prana, Ayurvedic medicine, 3 |
|
|
|
 |
|
|
|
|
Prayer, value of, 249-250, 253, 254 |
|
|
|
 |
|
|
|
|
Pregnenolone |
|
|
|
 |
|
|
|
|
as a supplement, 241-242 |
|
|
|
 |
|
|
|
|
distributor of, 390 |
|
|
|
 |
|
|
|
|
Price, Weston A., 43 |
|
|
|
 |
|
|
|
|
Prickly ash (Zanthoxylum), xerostomia, 144, 151, 306 |
|
|
|
 |
|
|
|
|
Proanthocyanidin oligomers (PCOs), flavonoid, 59, 305t |
|
|
|
 |
|
|
|
|
Probioplex®, distributor of, 391 |
|
|
|
 |
|
|
|
|
Processed foods, 44 |
|
|
|
 |
|
|
|
|
organic brands of, 354 |
|
|
|
 |
|
|
|
|
Progression, cancer stage, 33 |
|
|
|
 |
|
|
|
|
Promotion, cancer stage, 33 |
|
|
|
 |
|
|
|
|
Propolis, bee resin, 145 |
|
|
|
 |
|
|
|
|
Prostaglandins, 46, 47t |
|
|
|
 |
|
|
|
|
Prostate cancer |
|
|
|
 |
|
|
|
|
occurrences of, 339-340 |
|
|
|
 |
|
|
|
|
PC SPES, 168-169, 349t, 350, 351 |
|
|
|
 |
|
|
|
|
protocol for, 347-351, 349t |
|
|
|
 |
|
|
|
|
risk factors for, 340-341 |
|
|
|
 |
|
|
|
|
screening procedures, 341-342 |
|
|
|
 |
|
|
|
|
stages of, 344-344 |
|
|
|
 |
|
|
|
|
treatment of, 15-16, 344-347 |
|
|
|
 |
|
|
|
|
tumor-suppressor gene, 22 |
|
|
|
 |
|
|
|
|
Prostate Cancer: A Survivor's Guide, 294b |
|
|
|
 |
|
|
|
|
Prostate-specific antigen (PSA) test, 59, 341, 342 |
|
|
|
 |
|
|
|
|
Protease inhibitors, 52 |
|
|
|
 |
|
|
|
|
Protecting agents, chemotherapy, 279 |
|
|
|
 |
|
|
|
|
Protein |
|
|
|
 |
|
|
|
|
guidelines for, 64-66 |
|
|
|
 |
|
|
|
|
macronutrient, 48, 61-64 |
|
|
|
 |
|
|
|
|
metabolism, abnormalities of, 41 |
|
|
|
 |
|
|
|
|
Protein 95, distributor of, 391 |
|
|
|
 |
|
|
|
|
Protein 290, distributor of, 391 |
|
|
|
 |
|
|
|
|
Protein tyrosine kinase (PTK), 49, 52 |
|
|
|
 |
|
|
|
|
Proteoglycans (PGs), CAM, 36 |
|
|
|
 |
|
|
|
|
Proteolytic enzymes, 225-227 |
|
|
|
|
|